Press Release: Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Dow Jones
May 07

Financial release and supplemental presentation accessible online

BOSTON, May 7, 2026 /PRNewswire/ -- Haemonetics Corporation $(HAE)$ announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are available on the Company's Investor Relations website at www.haemonetics.com.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 7, 2026.

Conference Call and Webcast Information:

   -- Registration: Click here to register. Upon registration, participants 
      will receive dial-in details and a personalized PIN. While not required, 
      joining 10 minutes prior to the event start time is recommended. 
 
   -- Live webcast: Access here or through the Investor Relations section of 
      the Haemonetics website. 

A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on May 7, 2026 and will remain accessible for one year via the webcast link above.

Earnings Materials:

Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:

   -- Fourth Quarter Fiscal 2026 Earnings Release 
 
   -- Fourth Quarter Fiscal 2026 Supplemental Earnings Presentation 

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:

Olga Guyette, Vice President-Investor Relations & Treasury

(781) 356-9763

olga.guyette@haemonetics.com

David Trenk, Manager-Investor Relations

(203) 733-4987

david.trenk@haemonetics.com

Media Contact:

Josh Gitelson, Sr. Director-Global Communications

(781) 356-9776

josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-fourth-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302764893.html

SOURCE Haemonetics Corporation

 

(END) Dow Jones Newswires

May 07, 2026 06:00 ET (10:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10